CXCR3 and neoplasm: The antitumor activity of CD3xTRP1 in CXCR3 KO mice was significantly impaired compared to their WT counterparts, indicating that therapeutic efficacy was at least partially dependent on T cells’ ability to home towards the tumor (Fig. 1b and Supplementary Fig. 1a, b).